Pulmonary metastasectomy for soft tissue sarcoma - Report from a dual institution experience at the Medical University of Vienna

Median overall survival in this selected patient cohort is 45.3 months. Despite the lack of prospective randomised controlled trials, PM is a reasonable treatment strategy in selected patients.